Onyisi Christiana Didamson
Rahul Chandran
Heidi Abrahamse- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa
Introduction: Photodynamic therapy (PDT) is a light-based technique used in the treatment of malignant and non-malignant tissue. Aluminium-phthalocyanine chloride tetra sulfonate (AlPcS4Cl)-mediated PDT has been well investigated on several cancer types, including oesophageal cancer. However, the effects of (AlPcS4Cl)-mediated PDT on DNA damage response and the mechanism of cell death in oesophageal cancer needs further investigation.
Methods: Here, we examined the in vitro effects of AlPcS4Cl-mediated PDT on cell cycle, DNA damage response, oxidative stress, and intrinsic apoptotic cell death pathway in HKESC-1 oesophageal cancer cells. The HKESC-1 cells were exposed to PDT using a semiconductor laser diode (673.2 nm, 5 J/cm2 fluency). Cell viability and cytotoxicity were determined by the ATP cell viability assay and the lactate dehydrogenase (LDH) release assay, respectively. Cell cycle and DNA damage response (DDR) analyses were conducted using the Muse™ cell cycle kit and the Muse® multi-color DNA damage kit, respectively. The mode of cell death was identified using the Annexin V-FITC/PI detection assay and Muse® Autophagy LC3 antibody-based kit. The intrinsic apoptotic pathway was investigated by measuring the cellular reactive oxygen species (ROS) levels, mitochondrial membrane potential (ΔΨm) function, cytochrome c levels and the activity of caspase 3/7 enzymes.
Results: The results show that AlPcS4Cl-based PDT reduced cell viability, induced cytotoxicity, cell cycle arrest at the G0/G1 phase, and DNA double-strand break (DSB) through the upregulation of the ataxia telangiectasia mutated (ATM), a DNA damage sensor. In addition, the findings showed that AlPcS4Cl-based PDT induced cell death via apoptosis, which is observed through increased ROS production, reduced ΔΨm, increased cytochrome c release, and activation of caspase 3/7 enzyme. Finally, no autophagy was observed in the AlPcS4Cl-mediated PDT-treated cells.
Conclusion: Our findings showed that apoptotic cell death is the main cell death mechanism triggered by AlPcS4Cl-mediated PDT in oesophageal cancer cells.
1 Introduction
Oesophageal cancer, a tumor arising from the oesophagus, poses a serious global health challenge with increased cancer-related illness and death rates. Global Cancer Observatory observed that the incidence-to-death rate ratio of oesophageal cancer is increasingly alarming. Oesophageal cancer is associated with delayed diagnosis due to lack of symptoms, resulting in inadequate treatment outcomes and reduced survival rates (1, 2). Conventional treatment approaches, which consist of surgery, chemotherapy, and radiotherapy, have made significant advancements in the diagnosis and treatment of oesophageal cancer, notwithstanding the inability to eliminate this tumor is still a great source of concern. Hence, there is an urgent need for other therapeutic options that can preferentially attack tumor cells while sparing healthy tissues. In recent years, photodynamic therapy (PDT) has evolved as a potential treatment strategy for different types of cancers, including oesophageal cancer (3–7). PDT is a less invasive light therapy that utilizes the cytotoxic actions of a photoactivated agent known as photosensitizer (PS) (8). PDT has the potential to eliminate tumor cells by triggering programmed cell death (apoptosis and autophagy) and non-programmed cell death (necrosis) (9, 10). Clinically, PDT has been approved for the treatment of benign, superficial and late-stage oesophageal cancers either as curative or salvage therapy (5–7, 11). In clinical practice, PDT is performed via a flexible laser endoscopy system. The detailed procedures on how the PS is delivered and how the tumor of interest is differentiated from normal tissue can be found in references (11–15).
Various PSs have been employed for oesophageal cancer PDT, including porfimer sodium, porphyrins, chlorins, pheophorbides, 5-aminolevulinic acid and phthalocyanine (16). Phthalocyanine and its subtypes have been widely evaluated for the therapeutic application of oesophageal cancer (17–19). This is due to its high absorption wavelength in the therapeutic window and its excellent induction of reactive oxygen species (ROS), which is crucial in promoting cell damage. Aluminium-phthalocyanine chloride tetra sulfonate (AlPcS4Cl), a sub-class of phthalocyanine, has been extensively employed for PDT application on several tumor types, including oesophageal cancer (3, 20–23). It has been established that the subcellular localization of any PSs decides the effectiveness of PDT and, consequently, the cell death pathway (24). Studies have demonstrated that AlPcS4Cl is localized in the mitochondria, lysosome, cytoplasm, and nucleus (20, 25). Suggesting that AlPcS4Cl localization in these organelles dictates the mode of cell death. Reports show that PSs accumulating in the mitochondria, lysosomes, and nuclei promote apoptosis, while cytoplasm/plasma membrane localization causes necrosis. Aside from PS localization, the PS concentration and the light dose also influence the mode of cell death. In addition, PSs localizing in the nuclei induce apoptosis through a DNA damage-dependent pathway (26–29).
Studies have shown that DNA-damaging drugs could trigger the DNA damage response (DDR) pathways (30–32). The DDR pathway is usually confirmed by increased expression of specific proteins, which include ataxia telangiectasia mutated (ATM). ATM is a key protein that is upregulated by DNA double-strand breaks (DDSB). It functions as an upstream protein that facilitates the phosphorylation of histone H2A variant X (H2A.X) and the activation of p53 for various types of DNA repair responses (33, 34). Previous reports have shown that phthalocyanine-based photosensitizers can induce DNA damage and cell death across multiple cancer types (35, 36). However, the mechanism by which AlPcS4Cl induce DNA damage response and cell death in the oesophageal cancer cell is not clear. In this work, we evaluated the impacts of AlPcS4Cl-mediated PDT in triggering oxidative stress, DNA damage response, cell cycle arrest and apoptosis via the intrinsic pathway in oesophageal cancer cells. The results showed that AlPcS4Cl-mediated PDT induced oxidative imbalance, G0/G1 phase cell cycle arrest, caused DNA damage via DNA double-strand break and the upregulation of ATM kinase. In addition, AlPcS4Cl-mediated PDT triggered cell death via the intrinsic mitochondrial apoptotic pathway in vitro in human oesophageal cancer cells.
2 Materials and methods
2.1 Cell culture
The human oesophageal cancer cell line (HKESC-1 (RRID: CVCL_D568)) was commercially obtained from Cellonex, Johannesburg, South Africa. The HKESC-1 was cultivated in Dulbecco’s modified Eagle’s medium (DMEM) (D5796, Sigma-Aldrich) with the addition of 10% Foetal Bovine Serum (FBS) (Biochrom, S0615), 1 mM sodium pyruvate, 1% antibiotic (Amphotericin B and Penicillin-streptomycin). The cells were sustained and kept in a tissue culture incubator with the following conditions: 5% CO2, 80% humidity and 37°C temperature.
2.2 Preparation of AlPcS4Cl photosensitizer stock solution and UV-Vis spectrophotometry analysis
The AlPcS4Cl (AlPcS-834, Frontier Scientific) with a chemical formula C32H16AlClN8O12S and a molecular weight of 895.21 g/mol was protected from light and stored at room temperature. A stock concentration of 0.001 M was prepared by dissolving 0.013428 g of AlPCS4Cl in 15 mL of deionized water. The prepared stock solution was aliquoted, wrapped with aluminium foil, protected from light and stored in the fridge at 4°C. The UV-Vis spectrophotometry analysis was performed to determine the absorption spectrum of AlPcS4Cl, and the wavelength required for PDT application. The GENOVA NANO spectrophotometer (Jenway, 67912) was used to measure the absorption spectrum of AlPcS4Cl solution through a wavelength range of 400-800 nm.
2.3 Intracellular localization of AlPcS4Cl
The cellular localization of AlPcS4Cl in HKESC-1 oesophageal cancer cells was conducted as previously described (20). Cells were grown at a seeding density of 5 x 105 cells on glass coverslips in 35 mm culture dishes containing 2 mL of complete pre-warmed DMEM culture medium. The cells were maintained in 5% CO2, 85% humidity, and a 37°C incubator until they were attached. After attachment, the cells were washed three times with HBSS (Hanks’ Balanced Salt Solution) and then replaced with 2 mL of fresh pre-warmed complete DMEM culture media containing 20 µM of AlPcS4Cl. The cells were incubated for four hours to allow for effective intracellular accumulation. After incubation, the cells were rinsed three times with HBSS and fixed with 1 mL of paraformaldehyde (4%) for 15 minutes. The cells were rinsed, and 1 mL of 0.5% Triton X-100 was applied and allowed to stay for 10 minutes for permeabilization. The cells were rinsed again, and the cells’ organelles, such as mitochondria, lysosomes, and endoplasmic reticulum (ER), were labeled with 50µL of Mito-Tracker (100 nM) (M7514, Invitrogen™)), Lyso-Tracker (65 nM) (L7526, Invitrogen™), and ER-Tracker (65 nM) (E12353, Invitrogen™)), accordingly. The cells were kept on ice for 30 minutes and protected from light. Afterwards, the cells were rinsed, stained with 200 µL of 40,6- diamidino-2-phenylindole (DAPI) (D1306, Invitrogen™) and incubated for 5 minutes at room temperature. The coverslips were washed and mounted onto glass slides using a mounting media. Images were viewed using a Carl Zeiss Axio Z1 microscope with a 20x objective using the following filters: FITC (for Mito-tracker, lysotracker and ER-tracker), DAPI (nucleus), and AF660 filters for AlPcS4Cl. Zeiss Zen Blue 3.7 software was used for image acquisition.
2.4 Dose-response, laser parameters and PDT treatment
HKESC-1 oesophageal cancer cells were cultured at a seeding density of 5 x 105 cells in 35 mm culture plates containing 2 mL of complete DMEM culture medium. The cells were placed in a 5% CO2, 85% humidity incubator, and 37°C incubator for 24 hours for adequate attachment. After 24 hours of incubation, the cells were rinsed thrice with HBSS and then replaced with 2 mL of fresh pre-warmed complete DMEM culture media containing 1.25, 2.5, 5, 10, and 20 µM of AlPcS4Cl. The cells were incubated for four hours to allow for effective intracellular accumulation, as previously reported (20, 37). The cells were grouped into two: AlPcS4Cl at 0 J/cm2 (no PDT) and AlPcS4Cl-PDT at 5 J/cm2. After incubation, the AlPcS4Cl-PDT cells were rinsed three times with HBSS, and 1 mL of 1 x phosphate-buffered saline (PBS) was added to the plates and then ready for irradiation. A 673.2 nm semiconductor laser diode (Arroyo, High Power Laser, National Laser Centre of South Africa) with a power output of 97 mW was utilized for irradiation. Prior to irradiation, the power output was measured with the field mate laser power meter and the reading obtained was used to determine the irradiating time. The cells were irradiated for eight minutes at a fluency of 5 J/cm2. After irradiation, the 1 x PBS was removed, and the cells were replenished with 2 mL of a complete DMEM culture medium. The cells with no PDT AlPcS4Cl at 0 J/cm2 were rinsed three times with HBSS and replaced with 2 mL of a complete DMEM culture medium. The two groups of cells were further incubated for 24 hours in a 5% CO2 and 85% humified incubator at a temperature of 37°C. All irradiation procedures were conducted in the dark to prevent background light interaction. The formula below was used to estimate the fluency.
P cell viability and cytotoxicity assays were conducted to determine the effects of AlPcS4Cl on HKESC-1 cells with various concentrations (1.25, 2.5, 5, 10, and 20 µM) with or without PDT treatment. A dose response was performed on HKESC-1 cells to obtain the appropriate concentration of AlPcS4Cl required for the downstream application of PDT on HKESC-1 cells. The ATP cell viability results were used to identify the 50% inhibitory concentration (IC50). The IC50 concentration obtained from the cellular dose response of AlPcS4Cl-mediated PDT on oesophageal cancer cells was used to assess the mode of cell death triggered by AlPcS4Cl in Section 2.7.
2.5 Adenosine triphosphate cell viability assay
Adenosine triphosphate (ATP) cell viability was conducted using the CellTiter-Glo® 3D luminescence (G968, Promega). Briefly, 50 μL of cell suspension and 50 μL of CellTiter-Glo® 3D reagent were added to a 96-well plate and mixed properly, then incubated at room temperature for 10 minutes in the dark. The PerkinElmer VICTOR Nivo™ plate reader was used to measure the ATP luminescence.
2.6 Lactate dehydrogenase release assay
The cell membrane functionality of HKESC-1 cells was examined by measuring the efflux of lactate dehydrogenase (LDH) enzyme from impaired cell membranes of HKESC-1 cells. To evaluate LDH cytotoxicity, a CytoTox 96® Non-Radioactive Cytotoxicity assay (G1780, Promega) was used. Briefly, 50 μL of reconstituted reagent and equal volume cell culture medium were added into a 96-well plate and incubated for 30 minutes at room temperature. Absorbance was measured at 490 nm using the PerkinElmer VICTOR Nivo™ plate reader.
2.7 Mode of cell death evaluation
The mode of cell death induced by AlPcS4Cl-mediated PDT was evaluated using the IC50 concentration of 5 μM obtained from the cellular dose response in Section 2.4. HKESC-1 cells (5.0 x 105) were grown in 35 mm culture plates, and PDT treatment was performed as highlighted in Section 2.4. The cells were grouped into four categories: control, laser-only, AlPcS4Cl and AlPcS4Cl-PDT.
2.7.1 Cell morphology evaluation
Twenty-four hours following PDT, cells were checked for cellular morphological variation using an inverted light microscope (Olympus CKX41Q4) attached to a camera. The various oesophageal cancer cell groups were examined, and images were obtained using the 20X objectives with 100 µm scale bars. The images were checked for morphological variation in cell size, shape, structure, and attachment to the culture plate and compared in relation to the control cells.
2.7.2 Cell cycle assessment
Cell cycle assessment was carried out with the Muse™ Cell Cycle Kit (MCH100106, Millipore) using the assay’s protocol guide. After 24-hour PDT exposure, the cells were harvested, 1.0 x 106 cells/mL were washed 1 x PBS, and the supernatant was expelled. The cells were fixed in a newly prepared ice-cold 70% ethanol for 3 hours in a -20°C freezer. Following fixation, 200 μL of the cells were transferred into a new tube. The cells were washed in 1 x PBS, and the supernatant was discarded. The cells were resuspended in the Muse® Cell Cycle reagent (200 μL), kept at ambient temperature for 30 minutes without light, and analyzed using the Guava Muse Cell Analyzer (Millipore).
2.7.3 DNA damage response assessment
DNA damage response assessment was conducted with the Muse® Multi-Color DNA Damage Kit (MCH200107, Luminex) following the kit’s instructions. Following 24-hour post-PDT treatment, 50 μL volume of 1x assay buffer containing 1 x 105 cells and 50 μL fixation buffer were dispensed into a 1.5 microtube, mixed, and incubated for 10 minutes at 2-4°C. The cells were washed, the supernatant eliminated and permeabilized with ice-cold 1x permeabilization buffer (100 μL) for 10 minutes at 2-4°C. The cells were stained with 100 μL of diluted antibody cocktail (containing anti-phospho-ATM (Ser1981)-PE and anti-phospho-Histone H2A.X (Ser139)-PECy5 antibodies) and incubated for 30 minutes at room temperature in the absence of light. The cells were washed, the supernatant expelled and resuspended in 1x assay buffer (200 μL). The cells were analyzed with the Muse® Cell Analyzer.
2.7.4 Annexin V-FITC/PI assay
To examine the cell death mechanism in the control and treatment group, we used the Annexin V-FITC/PI (556570, BD Pharmingen™) flow cytometry assay. The percentage of apoptotic and necrotic cells was measured following the manufacturer’s manual. In summary, after 24 hours post-PDT, cells were detached, rinsed in ice-chilled 1 x PBS, and then recovered in 500 μL of binding buffer. A 100 μL of cells were transferred into sterile 5 mL tubes. The cells were stained with an equal volume of 5 μL of annexin V-FITC and of propidium iodide (PI). The tubes were kept for 15 minutes at ambient temperature and covered with foil. Following the 15-minute incubation, 400 μL of 1X binding buffer was pipetted into the tubes and kept in the dark for 30 minutes. The cells were analyzed using the Becton Dickinson (BD) flow cytometer Accuri™ C6. Annexin V–FITC binding was measured using FL1filter (FITC), and PI was measured with FL2 filter [phycoerythrin (PE)]
2.7.5 Detection of reactive oxygen species
Intracellular reactive oxygen species (ROS) levels were measured using the fluorescent probe 2′,7′-dichlorofluorescein diacetate (DCFDA/H2DCFD), cellular ROS assay (ab113851, Abcam). The HKESC-1 cells (10,000 cells/well) were grown in 96-well tissue culture plates for 24 hours for proper attachment. Twenty-four hours after PDT application, the cells were stained with 5 μM of DCFH-DA and kept for 10 minutes at 37°C temperature. Then the cells were added to a black plate of 96-well. The PerkinElmer VICTOR NivoTM plate reader was used to measure the fluorescence intensity using an excitation/emission filter of 485 nm/538 nm wavelength. Mitochondrial Membrane Potential Assessment
The rhodamine-123 (ab275545, Abcam) efflux flow cytometry assay, as previously described (21), was used to assess the mitochondrial membrane potential (ΔΨM). Rhodamine-123 is a fluorescent dye that localizes in mitochondria, and when the mitochondria membrane potential is impaired, the rhodamine leaks out, reducing the fluorescence intensity of the cell. Briefly, 24 hours following PDT treatments, cells were detached, harvested, and washed twice in 1x PBS. The cell pellets were recovered in 100 μL of 1 x PBS and treated in 25 μM of rhodamine 123. The cells were incubated in the dark at ambient temperature for 15 minutes and then were washed. The cell pellets were suspended in 400 μL of 1 x PBS, homogenized and kept in the dark at room temperature for half an hour. The rhodamine-123 fluorescent intensity was measured using an Accuri™ C6 BD flow cytometer with the FL1-H filter and evaluated with BD CSampler software.
2.7.6 Cytochrome c release assessment
The human cytochrome c ELISA assay (BMS263, Invitrogen) was utilized to measure the amount of cytochrome c release in the cell lysate. The test was performed according to the manufacturer’s directives. Briefly, 24 hours post-PDT, 1.5 x 106 cells were lysed with 1 mL lysis buffer for one hour at room temperature. The cells were centrifuged for 15 minutes at 200 x g, and 5 μL of the lysate was diluted in 245 μL of 1 x assay buffer. One hundred microlitres of the diluted lysate and 50 μL of biotin-tagged anti-human cytochrome c antibody were added into the microwell strips. The microwell strips were incubated for two hours at room temperature and thereafter rinsed with wish wash buffer. Streptavidin-HRP secondary antibody (100 μL) was dispensed into the microwells and incubated for 60 minutes at ambient temperature. The microwells were washed, tetramethyl-benzidine substrate (100 μL) was added, and after 10 minutes, 100 μL of stop solution was added. The cytochrome c levels were measured using the PerkinElmer VICTOR Nivo™ microplate reader set at 450 nm.
2.8 Measurement of Caspase 3/7 activity
The Caspase-Glo 3/7 luminescent assay kit (G8090, Promega) was used to detect the caspase 3/7 levels. The assay was conducted using the manufacturer’s instructions. Briefly, 24 hours post-PDT, 50 μL volume each of Caspase-Glo 3/7 luminescence reagent and the cell suspension was added in a 96 microwell plate, mixed, and incubated for about 30 minutes to 3 hours at room temperature in the dark. The Caspase-Glo 3/7 luminescence produced was measured with the plate reader PerkinElmer, VCTOR Nivo™.
2.9 Autophagy evaluation
Autophagy detection was conducted using the Muse® Autophagy LC3 antibody-based kit (MCH200109, Luminex). Briefly, cells were cultured at a cell concentration of 4.0 x 104 cells/well in a 96-well plate for 24 hours and subjected to PDT. Following 24 hours post-PDT, the cells were treated with 200 μL of autophagy reagent A and incubated for 4 hours at 37°C. The cells were harvested, spun down at 300 x g for 5 minutes, and the supernatant was discarded. The cells were stained with 100 μL of diluted Anti-LC3 Alexa Fluor™ 555 antibody and kept at 2 – 4°C for half an hour without light. The cells were centrifuged, and the supernatant was eliminated. The residual cells were washed with 1x assay buffer, centrifuged, and the supernatant expelled. The residual cells received 200 μL of 1x assay buffer and were adequately mixed and measured using the Muse® Cell Analyzer. The autophagy induction ratio was obtained by calculating the ratio of the mean autophagy intensity of the test sample and the mean autophagy intensity of the control sample. Values ≥1 denote autophagy induction, and ≤1 depicts no induction.
2.10 Statistical analysis
All experimental results were collated from three replicates of two independent experiments and are demonstrated as the mean ± SEM (standard error of the mean). Statistics were conducted using a one-way variance analysis using the GraphPad Prism version 5 (GraphPad Inc., San Diego, CA, USA). Statistical significance was set at P<0.05.
3 Results
3.1 Absorption spectrum and chemical structure of AlPcS4Cl
The absorption spectrum of AlPcS4Cl was analyzed using UV-Vis Spectrophotometry, and results showed the highest absorption at 675 nm when measured from 200 nm to 800 nm wavelength. Figure 1 shows the wavelength at which AlPcS4Cl has the maximum absorption. Also present in this spectrum (Figure 1A) is a medium peak called the soret band at ± 350 nm. This wavelength can be used for fluorescence detection in photodiagnosis. For AlPcS4Cl-mediated PDT in this study, a 673.2 nm semiconductor diode laser was utilized. The structure of AlPcS4Cl shows the core porphyrin structure and the presence of the phenyl/aromatic rings and sulfonic acid functional groups (Figure 1B).
Figure 1 (A) Spectral absorption of AlPcS4Cl indicating the highest peak at 675 nm. (B) Chemical structure of AlPcS4Cl.
3.2 Intracellular localization of AlPcS4Cl
Intracellular localization of AlPcS4Cl in HKESC-1 oesophageal cancer cells was performed four hours post PS incubation using organelle-specific trackers labeled with fluorescence probe and observed with fluorescence microscopy. The following intracellular organelles, such as mitochondria, lysosome, and ER, were stained using the mito-tracker, lysotracker, and ER tracker fluorochrome, respectively. At the same time, the nuclei were counterstained with DAPI. In Figure 2, the blue fluorescence indicates the nuclei, the red fluorescence denotes AlPcS4Cl, and the green fluorescence represents the mitochondria, lysosomes, and ER. The merged yellow/white and pink colours showed an accumulation of AlPcS4Cl in the mitochondria, lysosome, ER, and nucleus.
Figure 2 The nuclei are counterstained with DAPI (blue), mitochondria, lysosome, ER stained with FITC (green), and AlPcS4Cl auto fluoresces (red). The merged yellow/white and pink colours showed an accumulation of AlPcS4Cl in the mitochondria, lysosome, ER, and nucleus.
3.3 Cellular viability and determination of 50% inhibitory concentration (IC50) of AlPcS4Cl in oesophageal cancer cells
An ATP cell viability analysis was performed to determine the ability of AlPcS4Cl to inhibit HKESC-1 cancer cells. High cell viability was seen in the control group, and the group administered AlPcS4Cl without irradiation (0 J/cm2) (Figure 3A). This result showed that AlPcS4Cl is non-toxic in the inactivated state. Conversely, the PDT-treated cells exposed to 5 J/cm2 irradiation showed a significant reduction of cellular ATP generation when compared to the control (*p<0.05, ***p<0.001) (Figure 3B), which is an indication of non-viable cells. This reduction follows a dose-dependent pattern: the higher the concentration, the lower the cell viability/ATP production. This observation demonstrated that AlPcS4Cl-mediated PDT inhibited cell viability and cell growth, consequently leading to cell death. Furthermore, we evaluated the IC50 concentration on the cancer cells to identify the appropriate concentration of AlPcS4Cl needed for downstream PDT application. The IC50 values were performed with ATP cell viability assay following 24 hours post-PDT using the following concentrations of AlPcS4Cl (1.25, 2.5, 5, 10, and 20 µM). The IC50 concentration was estimated by calculating the inhibition of luminescence of ATP cellular viability using the log(inhibitor) versus normalized response-variable slope equation in GraphPad Prism, version 5.0.
Figure 3 ATP cell viability of AlPcS4Cl treated oesophageal cancer cells using the ATP cell viability luminescence assay. The relative luminescent unit (RLU) is proportional to the ATP level in the cell/cell viability. (A) Control cells and cells treated with different amounts of AlPcS4Cl without photoactivation (0 J/cm2) displayed high ATP levels/viability. No statistically significant was observed. (B) Irradiated cells receiving varying concentrations of PDT at 5 J/cm2 exhibited reduced ATP levels and cell viability, with a significant reduction seen in the cells receiving 5 μM, 10 μM and 20 μM at 5 (*p<0.05, ***p< 0.001). (C) The IC50 viability concentration of AlPcS4Cl on HKESC-1 cells. The values displayed are mean ± SEM (standard error of the mean) of three replicate tests from two separate experiments.
Where Y represent the % inhibition of cell viability and X the concentration of AlPcS4Cl.
In Figure 3C, the result showed that AlPcS4Cl exhibited an IC50 value of 5.05µM on oesophageal cancer cells. The IC50 of 5 µM was used for all cell death PDT investigations in Section 3.5.
3.4 Lactate dehydrogenase release mediated by AlPcS4Cl-PDT
To determine the cytotoxicity impact of AlPcS4Cl on HKESC-1 oesophageal cancer cells, a lactate dehydrogenase (LDH) release cytotoxicity assay was conducted. The LDH assay is established on the principle that cells with disrupted cell membranes expel LDH, denoting cytotoxicity. The cytotoxicity impact on the cancer cells was examined 24 hours after PDT by quantifying the amount of LDH enzyme that was leaked into the culture media. Low LDH activities were observed in the control cells and the cells exposed to AlPcS4Cl 0 J/cm2 (Figure 4A). This result further confirmed the non-toxic effect of AlPcS4Cl when not activated. Figure 4B showed that the cells treated with PDT showed a dose-responsive high release of LDH, indicating cell membrane impairment. The results showed that AlPcS4Cl-mediated PDT drives cell membrane disruption and cell death.
Figure 4 The cytotoxic effects of AlPcS4Cl on oesophageal cancer cells. The LDH release cytotoxicity assay on HKESC-1 cells was measured 24 hours following PDT. (A) The amount of LDH leakage in the control groups at 0 J/cm2. Demonstrating no significance. (B) the PDT-treated cells exhibited a high statistical significance difference in relation to the control (*p<.05, **p< 0.001). The results are depicted as the mean ± SEM of three repeats from two individual experiments.
3.5 Evaluation of cell death mechanism
3.5.1 Effects of AlPcS4Cl-mediated PDT on the morphology of oesophageal cancer
The different forms of cell death mechanisms can be identified based on their cellular morphological changes. The morphological examination was carried out 24 hours after PDT on four groups of oesophageal cancer cells (control, laser-only, AlPcS4Cl and AlPcS4Cl-PDT) using an IC50 of 5µM. The control, laser-only and AlPcS4Cl displayed active proliferative cells with no morphological changes (Figures 5A–C). The AlPcS4Cl-PDT group irradiated at 5 J/cm2 showed significant morphological alterations (Figure 5D). The morphological changes noted were cell contraction, blebbing, cell rounding up, and damaged cell membrane. These features were marks of cell death events.
Figure 5 Morphological examination of oesophageal cancer cells as shown with 20X objective magnification displaying healthy cellular structure in the control, laser-only, AlPcS4Cl alone (A–C) and significant cellular impairment in theAlPcS4Cl-mediated PDT treated cells (D).
3.5.2 AlPcS4Cl-mediated PDT induced cell cycle arrest at the G0/G1 phase in oesophageal cancer cells
Aggressive cell growth is a major characteristic of tumor cells, which is usually driven by dysregulation of the cell cycle. The Muse Cell cycle kit was employed to investigate the effects of AlPcS4Cl-mediated PDT on the cell cycle. The cell cycle distribution results (Figures 6A–D) following 24-hour post-PDT exposure displayed the DNA content of the various cell cycle phases in the different experiment groups using Muse Cell Analyzer. Increased DNA content at the G0/G1 phase was observed in the AlPcS4Cl-PDT treated cells when compared with the control cells(***p<0.001) (Figure 6E blue bars). The laser-only and AlPcS4Cl-only groups displayed identical G0/G1 phase features with that of the control cells. The S phase (Figure 6E red bars) showed reduced DNA contents in the cells exposed to AlPcS4Cl-PDT treatment in relation to the control cells (***p<0.001). No significance was found in the laser-only and AlPcS4Cl-only groups relative to the control cells. The G2/M phase in Figure 6E (green bars) exhibited a significant reduction in the DNA contents in the cells receiving AlPcS4Cl-PDT treatment (***p<0.001), and no significance was demonstrated in the laser-only and AlPcS4Cl cells. These findings indicate that AlPcS4Cl-PDT treatment induces cell cycle arrest at the G0/G1 phase in oesophageal cancer cells. In addition, a significant defect in the G2/M checkpoint activity was noted in the AlPcS4Cl-PDT treated cells.
Figure 6 Cell cycle checkpoint evaluation of oesophageal cancer cells. The distribution of the respective cell cycle checkpoint phases (A) control untreated cells, (B) laser-only, (C) AlPcS4Cl and (D) AlPcS4Cl-PDT cells. The blue, red and green histograms represent the G0/G1, S and G2/M cell cycle checkpoint phases, respectively. (E) Percentage evaluation of three assays from two separate cell cycle analyses, with AlPcS4Cl-PDT showing G0/G1 cell cycle arrest compared to the control, laser and AlPcS4Cl only cells (***p< 0.001). The values shown are the mean ± SEM of triplicate tests from two independent experiments.
3.5.3 DNA damage response induced by AlPcS4Cl-PDT
The Muse Multi-Color DNA Damage Kit was employed to investigate the DNA damage response proteins ATM (ataxia-telangiectasia mutated) and H2A.X (histone H2A variant X)using Muse Cell Analyzer. This assay concurrently detects the expression of phosphorylated ATM, H2A.X and detection of DNA double-strand break (DSB) (co-expression of ATM/H2A.X cells) in the control and AlPcS4Cl -PDT treated oesophageal cancer cells. Figures 7A–D displayed the DNA damage response distribution of oesophageal cancer cells in the various groups.
Figure 7 Quadrant profiles of DNA damage response assessment of oesophageal cancer cells exposure to treatment. Upper left: phosphorylated ATM, lower left: no DNA damage, upper right: double-strand break (DSB) (co-expressing ATM, H2A.X) and lower right: phosphorylated H2A.X. (A) control untreated cells, (B) laser-only, (C) AlPcS4Cl and (D) AlPcS4Cl-PDT. (E) DNA damage response of two independent triplicate tests depicted in bar graphs. The pATM-activated cell (red bars) showed increased activity in AlPcS4Cl-PDT, treated oesophageal cancer cells compared to the control (***p<0.001). The double-strand break (DSB) (green bars, co-expressing pATM/pH2A.X) showed a significant increase in the induction of DSB in the cells exposed to AlPcS4Cl-PDT relative to the control cells (***p<0.001). No significant expression of pH2A.X was observed in all the groups. The no DNA damage (blue bars) shows a significant reduction in the AlPcS4Cl-PDT treated cells compared to the control (***p<0.001). The results are the mean ± SEM of triplicate assays from two independent experiments.
The exposure of oesophageal cancer cells to AlPcS4Cl-PDT in Figure 7E significantly triggered DNA damage, as demonstrated in the high expression of ATM phosphorylation and increased DNA DSBs relative to the control cells (***p<0.001) (Figure 7E, red and green bars). Nevertheless, no significant DNA damage was demonstrated in the laser-only and AlPcS4Cl cells. The findings showed that AlPcS4Cl-PDT, treated oesophageal cancer cells, triggered DNA damage response signaling via DNA double-strand break and ATM pathways.
3.5.4 Induction of apoptosis by AlPcS4Cl-mediated PDT
Cell death evaluation was conducted with the annexin V-FITC/PI detection kit. In Figures 8A–D, the result showed a quadrant display of different phases of cell death (control, laser only, AlPcS4Cl and AlPcS4Cl-PDT). Oesophageal cancer cells treated with 5µM AlPcS4Cl-PDT showed a high percentage of early apoptotic cell death (30.7%) as against 17.7%, 15.6% and 12.5% in the control, laser-only and AlPcS4Cl-only cells respectively. The statistical significance of three repeated duplicate experiments was demonstrated in a bar graph, as seen in Figure 8E. The cells treated with AlPcS4Cl-PDT at 5 J/cm2 showed a significant reduction in viable live cells and increased early apoptosis (**p<0.01). However, no significant difference was seen among the treated cells and the various control cells in the necrotic and late apoptotic cell death fractions.
Figure 8 Cell death annexin V-FITC/PI of oesophageal cancer cells. Quadrant display of different phases of cell death (A–D) (control dark, control + irradiation, AlPcS4Cl dark and AlPcS4Cl-PDT). (E) Percentage quantification of triplicate tests from two independent cell death annexin V-FITC/PI assays on oesophageal cancer cells. The AlPcS4Cl-PDT treated cells showed a significant reduction of live cells (red bars) and a high percentage of early apoptosis (blue bars) compared to the control, laser only, and AlPcS4Cl cells (**p<0.01). The results are shown as the mean ± SEM of triplicate tests from two separate experiments.
3.5.5 AlPcS4Cl-mediated PDT induces ROS production and alters mitochondrial membrane potential
Several cellular stresses are activators of the intrinsic pathway of apoptosis. Cellular ROS have been observed to be associated with the initiation of the mitochondria-dependent cell death pathway. ROS can damage the mitochondria membrane, leading to the release of several mitochondrial proteins into the cytosol. These proteins interact with other proteins in the cytosol, resulting in the activation of caspases and, consequently, cell death (38). The DCFH-DA probe was used to determine the amount of ROS produced upon irradiation of 5µM AlPcS4Cl-PDT-treated HKESC-1 cells relative to the control cells. A significantly higher amount of ROS was seen in the cells exposed to AlPcS4Cl-PDT (p<0.001) (Figure 9A), demonstrating that ROS is a key driver of intrinsic cell death initiated by AlPcS4Cl-mediated PDT. Meanwhile, the laser-only and AlPcS4Cl presented similar ROS generations to those of the control cells.
Figure 9 (A) The Cellular Reactive Oxygen Species (ROS) generation of AlPcS4Cl in HKESC-1 oesophageal cancer cells. Results showed an increased production of ROS in the AlPcS4Cl -PDT treated cells (***p< 0.001). (B) The impact of AlPcS4Cl on the Mitochondria membrane potential (Δψm) of oesophageal cancer cells. Rhodamine-123 efflux assay was used for evaluating the Δψm. Increased distortion of the Δψm was observed in control irradiated cells and AlPcS4Cl-PDT cells treated with 5 J/cm2 irradiation ***p< 0.001), with no significance shown in control dark and AlPcS4Cl dark cells. The results are depicted as the mean ± SEM of triplicate determinations from two independent experiments.
Damage to the inner mitochondrial membrane potential (ΔΨm) is an outcome that is linked with the intrinsic pathway of apoptotic cell death (39). The effects of AlPcS4Cl on the mitochondrial integrity of oesophageal cancer cells were assessed using a rhodamine-123 efflux flow cytometry assay. Rhodamine-123 is a fluorescent dye that accumulates in intact mitochondria. An impaired mitochondria membrane results in reduced accumulation of the rhodamine dye, consequently leading to low fluorescence intensity. Rhodamine-123 efflux flow cytometry assay was employed to examine the mitochondria. In this assay, mitochondria with intact structures exhibit a high percentage of Δψm, and damaged mitochondria show a low percentage of Δψm. In Figure 9B, the percentage of Δψm was measured, and samples were compared in relation to the control cells. No statistical significance was observed among the control cell and AlPcS4Cl-only cells. In contrast, cells exposed to PDT at 5 J/cm2 demonstrated a statistically significant reduction in Δψm (***p< 0.001) compared to the control cells. Interestingly, laser-only (cells exposed to 5 J/cm2 irradiation with drug) showed a statistically significant decrease in Δψm (***p< 0.001).
3.5.6 AlPcS4Cl-mediated PDT triggers cytochrome c release and caspase 3/7 Enzyme activity
Cytochrome c plays a crucial role in oxidative phosphorylation and ATP generation. Damaged mitochondria trigger the release of several proteins, including cytochrome c. The levels of cytochrome c release were measured post-PDT. The results showed low cytochrome c levels in the control cells, laser-only, and AlPcS4Cl non-irradiated with no statistical difference observed (Figure 10A). The reduced cytochrome c levels demonstrated in the control cells, laser-only, and AlPcS4Cl non-irradiated cells implied undamaged and viable mitochondria. While the 5 µM AlPcS4Cl-PDT treated cells (Figure 10A) showed significantly high levels of cytochrome c (***p<0.001). This finding suggested impaired mitochondria, hence the efflux of cytochrome c protein into the cytosol. This outcome validates the intrinsic mitochondria apoptotic cell death pathway instigated by the AlPcS4Cl-mediated PDT on oesophageal cancer cells.
Figure 10 (A) Cytochrome c enzyme release mediated by AlPcS4Cl-PDT treated HKESC-1 oesophageal cancer cells. The AlPcS4Cl-PDT treated group exhibited a significant release of cytochrome c when examined in relation to the control, laser only, and AlPcS4Cl cells (***p<0.001). (B) Caspase 3/7 activity measurements on HKESC-1 oesophageal cancer cells exposed to AlPcS4Cl. The AlPcS4Cl-PDT treated group showed high significance of caspase 3/7 activity relative to the control, laser only, and AlPcS4Cl cells (***p<0.001). The bar graphs are shown as the mean ± SEM of three replicates from two individual experiments.
Caspases are proteolytic proteins required in the activation and enforcement of apoptosis. The initiation of these proteins is usually seen as a final indicator of apoptosis (40). Cytochrome c leakage from damaged mitochondria promotes cell death through the intrinsic apoptotic response by activating caspase 3/7 caspases, which are effector caspases (39). To further confirm the intrinsic apoptotic cell death induction by AlPcS4Cl-mediated PDT on oesophageal cancer cells, the caspase 3/7 luminescence assay was utilized to assess the activity of the caspase 3/7 enzyme. A significant increase in caspase 3/7 activity was observed, indicating a significant rise in the activity of this protein in the AlPcS4Cl-PDT treated group (***p<0.001) when compared with controls (Figure 10B).
3.5.7 Autophagy evaluation of AlPcS4Cl-mediated PDT on oesophageal cancer
The effects of AlPcS4Cl-mediated PDT on autophagy in oesophageal cancer cells were examined 24 hours after PDT using the Muse Autophagy LC3 antibody-based detection kit. The autophagy induction ratio was derived by using the ratio of the mean autophagy intensity of the test sample and the mean autophagy intensity of the control sample. Autophagy induction values ≥1 denote autophagy induction, and ≤ indicates no induction. The results in Figures 11A–D displayed the histogram of the mean autophagy intensity in the control and test groups. The control cells had an autophagy induction ratio of 1.0, depicting the absence of autophagy induction, laser-only treated cells 0.8, AlPcS4Cl treated cells without irradiation 0.9, and AlPcS4Cl-PDT treated cells 1.0. The percentage mean autophagy intensity of two separate autophagy triplicate assays in Figure 11E showed the laser-only and AlPcS4Cl treated cells had a significant reduction in the mean autophagy intensity (*p<0.05). No significant was observed in the AlPcS4Cl-PDT-treated cells. The autophagy induction ratio shows no significant induction in all the groups in Figure 11F.
Figure 11 Autophagy cell death evaluation on oesophageal cancer cells. Histogram of mean autophagy intensity in the control and test groups (A–D). (E) Percentage mean autophagy intensity of two separate autophagy triplicate assays, with the laser-only and AlPcS4Cl treated cell demonstrating a significant reduction in the mean autophagy intensity (*p<0.05). No significance was observed in the AlPcS4Cl-PDT-treated cells. (F) The autophagy induction ratio shows no significant induction in all the groups. The results are shown as the mean ± SEM of triplicate tests from two independent experiments.
4 Discussion
The application of AlPcS4Cl in PDT has been widely investigated on several cancers owing to its unique photochemical features (3, 20, 21, 23). The current study revealed that AlPcS4Cl-mediated PDT induced DNA damage response and intrinsic apoptosis pathway as observed by the localization of the PS in the mitochondria/nucleus, upregulation of ATM a DNA damage sensor, high ROS production, reduction in ATP level, decrease in ΔΨM, increase in apoptotic cells, and increment in cytochrome c and caspase 3/7 activity. First, we determine the spectral absorption feature of AlPcS4Cl to determine its absorption wavelength required for downstream PDT applications. One of the attributes of an effective PS is that it should possess a high absorption wavelength within the optical therapeutic window (600-800nm) for deeper tissue penetration (41). Our results showed that AlPcS4Cl display maximum light absorption (675nm wavelength) within the optical therapeutic window.
The intracellular localization of the PS, a parameter that determines the effectiveness of PDT, was examined. The site of accumulation of the PS dictates which intracellular organelles would be affected and the mode of cell death that would be activated (24). In this study, we observed the preferential sub-localization of AlPcS4Cl in mitochondria, lysosomes, ER and the nucleus. This implies that the AlPcS4Cl-mediated PDT mode of cell death could be dependent on these organelles. This agrees with a study by Ndhundhuma and colleagues demonstrating the localization of AlPcS4Cl in the mitochondria, lysosomes, and nuclei of melanoma cells (25). Also, other studies showed that AlPcS4Cl is accumulated in the mitochondria and lysosomes of lung tumor cells (20) and lung cancer stem cells (42). The internalization of the AlPcS4Cl in the nuclei of HKESC-1 oesophageal cancer cells suggests that this PS could induce cell death through the DNA damage response-dependent pathway.
Results from cell viability analysis using ATP cell viability assay demonstrated that the control cells without the drug and the cells administered with AlPcS4Cl (1.25- 20 µM) without irradiation (0 J/cm2) had active and viable cells with high ATP levels, indicating the non-toxicity action of AlPcS4Cl when inactive. However, AlPcS4Cl-mediated PDT exposed to 1.25 - 20 µM concentration irradiated at 5 J/cm2 significantly reduced cell viability and decreased ATP levels in a dose-dependent manner. The results also showed that AlPcS4Cl at 5 J/cm2 has an optimum phototoxic (IC50) effect of 5 µM on HKESC-1 oesophageal cancer cells. The cytotoxicity effects of AlPcS4Cl on HKESC-1 oesophageal cancer cells were assessed using the LDH release cytotoxicity assay, which detects the amount of enzymes relinquished into the culture medium following cell damage. The results showed a significantly higher LDH enzyme release in the AlPcS4Cl-mediated PDT group than in the control cells. This implies that AlPcS4Cl-mediated PDT promotes cytotoxicity in oesophageal cancer cells.
The mode of cell death induced by AlPcS4Cl-PDT in oesophageal cancer cells was carried out using various cell death assessment strategies. Findings from morphological assessment of cell death showed several morphological variations in the AlPcS4Cl-PDT group when compared to the control, which was suggestive of cell death. This finding validated the ATP cell viability and LDH cytotoxicity reports obtained in this study. Furthermore, this finding agrees with previous reports where they observed morphological distortion in cervical and lung cancer stem cells treated with zinc phthalocyanine and AlPcS4Cl-based PDT, respectively (42, 43). We evaluated the effect of AlPcS4Cl-PDT on the phases of the cell cycle in oesophageal cancer cells. The cell cycle is a well-coordinated multiple mechanism that regulates cell proliferation and DNA damage homeostasis to ensure that DNA lesions are not transferred to new daughter cells. The cell cycle is made up of four phases: gap 1(G1), synthesis (S), G2, and mitosis (M). Cell cycle checkpoints have emerged to regulate the cell cycle process in the event there is DNA damage (44). The proportion of cells in the G0/G1 phase significantly increased in the cancer cells exposed to AlPcS4Cl-PDT when compared to the control. Therefore, our findings imply that AlPcS4Cl-mediated PDT induced cell cycle arrest at the G0/G1 checkpoint. The precise mechanism by which AlPcS4Cl-mediated PDT interrupt cell cycle regulation requires further interrogation. Cell cycle mediating actions of AlPcS4Cl-PDT have been previously demonstrated to induce cell cycle arrest at the G0 phase in lung cancer (45). Likewise, zinc phthalocyanine tetra sulfonate-loaded nanoparticles were observed to inhibit the cell cycle at the G0 phase in colorectal cancer (46). Hence, the cell cycle arrest in the G0/G1 phase in HKESC-1 oesophageal cancer cells following exposure to AlPcS4Cl-mediated PDT may result from the accumulation of DNA damage.
One of the key causes of cell damage and death in PDT is oxidative DNA damage, which could be induced by free radicals. DNA damage may result in single or double-strand breaks (35, 47). When DNA damage occurs, repair mechanisms are activated to sustain the survival and stability of the DNA genome. This entire process in reaction to DNA damage is termed DNA damage response (DDR) (32). The effect of AlPcS4Cl-mediated PDT on DDR was examined. Exposure of HKESC-1 oesophageal cancer cells to AlPcS4Cl-mediated PDT significantly triggered double-strand break (DSB) DNA damage. It activated the upregulation of Ser1981 phosphorylated ATM, a DNA DSB sensor when compared to the control cells. A study by El-Hussein and colleagues demonstrated that zinc phthalocyanine-based PDT significantly induced DNA damage in lung, breast, and oesophageal cancer cells (36). Moreover, another study also showed that aluminium phthalocyanine tetra sulfonate (AlPcS4)-mediated PDT induced DNA damage in laryngeal cancer (35). The upregulation of ATM in response to DSB in our study is consistent with established evidence where ATM-mediated repair is believed to be the main mechanism in the DDR pathway to mend DSB lesions (33, 48). Furthermore, ATM functions in the regulation of cell cycle checkpoints following cellular stress, especially at the G0/G1, S, and G2/M cell cycle arrest (33, 49). This is in agreement with our cell cycle study, where we observed G0/G1phase cell cycle arrest. The activation of ATM results in the phosphorylation of several downstream proteins, such as H2A.X, which helps to intensify further the DNA DSB repair (34, 50). The downregulation of H2A.X in our study suggests that DNA repair may not have been successful. Cells exposed to DNA-damaging agents can decide to repair the DNA damage, tolerate the assaults or undergo cell death (32).
The mode of cell death mediated by AlPcS4Cl-based PDT on oesophageal cancer was performed using the annexin V-FITC/PI assay. The findings demonstrated that AlPcS4Cl-PDT trigger cell death via early apoptosis. However, a small percentage of necrosis was observed, which was lower than the control cells. No significant difference was seen between the AlPcS4Cl-PDT treatment group and the controls. This finding reported a similar cell death pattern observed by Ndhundhuma and Abrahamse (23) in melanoma cells treated with AlPcS4Cl mediated PDT using the Annexin V-FITC/PI assay. We also observed that the percentage of live cells in the control cells is low compared to the laser and AlPcS4Cl-only group. This observation is similar to the Annexin V-FITC/PI findings reported by Wei and colleagues in oesophageal cancer cells exposed to hematoporphyrin derivative (HpD)-PDT (51). The reason for this reduction is not clear.
Apoptosis has been observed to be activated by oxidative stress. We further examined if ROS initiated the observed induction of apoptosis. Apoptosis-linked ROS generation triggered by AlPcS4Cl-mediated PDT was investigated using the DCFDA/H2DCFD cellular ROS test. An increased amount of cellular ROS production was demonstrated in the cancer cells subjected to AlPcS4Cl-based PDT, establishing the activation of oxidative stress-related cellular damage in the oesophageal tumor cells. Increased ROS production may trigger DNA strand break, mitochondrial DNA impairment, and destruction of mitochondrial DNA (52). Oxidative stress and ROS have been implicated in promoting the mitochondria-dependent/intrinsic apoptotic cascade (53).
In normal cellular conditions, the mitochondria are the main source of cellular ATP production. However, in a disease state, the mitochondria serve as the primary source for oxygen radicals and ROS, blocking the normal function of ATP, preventing cell growth, facilitating the efflux of pro-apoptotic molecules and, consequently, cell death (38, 53). The effects of AlPcS4Cl on the ΔΨM of the HKESC-1 cancer cells were evaluated using the rhodamine-123 efflux flow cytometry assay. The findings demonstrated that AlPcS4Cl-upon irradiation significantly reduced the ΔΨM in the HKESC-1 oesophageal tumor cells. Also, this finding further confirmed the result from subcellular internalization, suggesting that the PS could trigger cell death via the intrinsic apoptotic pathway. This agrees with the finding that AlPcS4Cl reduce the ΔΨM in lung CSC (42). Reduction in ΔΨM is a critical step in the intrinsic apoptotic cascade. Impaired ΔΨM results in protein efflux from the inter-membrane space, such as cytochrome c, which activates other caspases involved in the activation and execution of apoptosis.
Cytochrome c is a protein involved in regulating cell growth and cell death. It functions in electron transfer as a component in the mitochondrial electron transport chain, and hence, it plays a vital role in the ATP generation process. It is also crucial in apoptosome formation and, consequently, induction of apoptosis (54). In this study, we employed ELISA to examine the levels of cytochrome c release in the cancer cells following treatment. High levels of cytochrome c release were demonstrated in the AlPcS4Cl-mediated PDT-treated cells than in the control cells. The findings validated that AlPcS4Cl-mediated PDT incurs damage to the mitochondria. This agrees with the study conducted by Mfouo-Tynga and colleagues (2018), where breast cancer cells treated with zinc-phthalocyanine-gold dendrimeric nanoparticles induced damage to mitochondria, resulting in the efflux of cytochrome c and apoptotic cell death (55). This also aligns with studies on human nasopharynx KB carcinoma cells (56) and melanoma cells (57) treated with zinc-phthalocyanine. The activation of the cytochrome c protein is an essential upstream process required to execute intrinsic apoptotic signaling pathways and caspase-dependent cell death. Caspase 3/7 activation is a crucial step that is required in the final execution of cell death in the apoptotic signaling pathway. In this study, the caspase 3/7 activity was elevated in the group exposed to AlPcS4Cl-mediated PDT. It has been established that a damaged ΔΨM releases various proteins that activate caspases, which are effectors of apoptosis (58). The high caspase 3/7 activity demonstrated here could be associated with the reduction in the ΔΨM observed in this study. Similar studies also reported activation of the caspase 3 enzyme in melanoma cells (57), human nasopharynx KB carcinoma cells, and breast cancer cells (55) exposed to zinc-phthalocyanine-mediated PDT. This further showed that AlPcS4Cl induce apoptotic cell death in oesophageal cancer via the intrinsic signaling cascade (Figure 12).
Figure 12 Proposed mechanism of AlPcS4Cl- mediated PDT triggered apoptosis in HKESC-1 oesophageal cancer cells through ROS generation, DNA damage, G0/G1 cell cycle arrest, mitochondrial damage, and caspase activation. ATM, ataxia-telangiectasia mutated; MMP, mitochondrial membrane potential; ATP, Adenosine triphosphate.
Finally, we examined the effects of AlPcS4Cl-mediated PDT on autophagic cell death using the Muse® Autophagy LC3 antibody-based detection assay on oesophageal cancer cells. Autophagy induction in relation to the control oesophageal cancer cells was evaluated. Our findings revealed that oesophageal cancer cells exposed to AlPcS4Cl-mediated PDT had no or little effect on LC3-II formation, a marker of autophagosome formation, demonstrating no autophagy induction in relation to that of the control cells. Thus, AlPcS4Cl-mediated PDT triggered no autophagy cell death action in HKESC-1 oesophageal cancer cells. Conversely, a study with zinc-phthalocyanine-based PDT on melanoma cells was shown to induce autophagy (59).
5 Conclusions
The findings presented here demonstrate that AlPcS4Cl-mediated PDT is an effective anti-cancer agent as observed through the induction of oxidative stress, DNA damage response and apoptotic cell death in oesophageal cancer cells. This induction is displayed through increased ROS generation, DNA double-strand breaks via upregulation of ATM response, cell cycle arrest at the G0/G1 phase, cellular ATP reduction needed for mitochondria function, increased damage in the ΔΨM, efflux of cytochrome c and high caspase 3/7 activity, which is the final steps of the apoptosis cascade. Our study thus uncovers the DDR pathway and intrinsic apoptosis cell death mechanism of AlPcS4Cl-mediated PDT in oesophageal cancer cells. Therefore, the ultimate outcome of AlPcS4Cl-mediated PDT-treated cells relies on the interplay between DNA damage repair and pro-apoptotic cell death mechanisms stimulated in response to oxidative stress. The significant sensitivity of HKESC-1-treated oesophageal cancer cells to DNA damage and DDR presents an excellent approach for blocking the DNA repair mechanisms involved in oesophageal cancer cells. This approach can potentially improve the efficacy of AlPcS4Cl-mediated PDT. More studies on other cell lines are needed to validate these findings. Further studies are also required to identify the interaction between DNA damage response and apoptosis using inhibitors of the DNA repair pathway and AlPcS4Cl-mediated PDT.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.
Author contributions
OCD: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft. RC: Supervision, Validation, Writing – review & editing. HA: Funding acquisition, Resources, Supervision, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by the University of Johannesburg Global Excellence and Stature, Fourth Industrial Revolution (GES 4.0) Doctoral Scholarship and the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (SARChI/NRF-DST) (Grant no: 98337).
Acknowledgments
The authors thank the University of Johannesburg and the Laser Research Centre for their facilities.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Footnotes
References
1. Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020. Gastroenterology. (2022) 163(3):649–58.e2. doi: 10.1053/j.gastro.2022.05.054
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660
3. Didamson OC, Chandran R, Abrahamse H eds. In vitro effects of aluminium (iii) phthalocyanine chloride tetra sulphonic acid-mediated photodynamic therapy on oesophageal cancer. In: The 66th annual conference of the South African institute of physics; 2022 4-8th july 2022; virtual. Pretoria, South Africa: The South African institute of physics (SAIP).
4. Filonenko EV, Sokolov VV, Chissov VI, Lukyanets EA, Vorozhtsov GN. Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther (2008) 5(3):187–90. doi: 10.1016/j.pdpdt.2008.06.001
5. Hayashi T, Asahina Y, Nakanishi H, Terashima T, Okamoto K, Yamada S, et al. Evaluation of the efficacy and safety of salvage photodynamic therapy by talaporfin sodium for cervical esophageal cancers and lesions larger than 3 cm. Esophagus. (2021) 18(3):645–54. doi: 10.1007/s10388-020-00799-6
6. Inoue T, Ishihara R. Photodynamic therapy for esophageal cancer. Clin Endosc. (2021) 54(4):494–8. doi: 10.5946/ce.2020.073
7. Ishida N, Osawa S, Miyazu T, Kaneko M, Tamura S, Tani S, et al. Photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer: A single center experience. J Clin Med (2020) 9(5):1509–19. doi: 10.3390/jcm9051509
8. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, et al. Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomedicine pharmacotherapy = Biomedecine pharmacotherapie. (2018) 106:1098–107. doi: 10.1016/j.biopha.2018.07.049
9. Mishchenko T, Balalaeva I, Gorokhova A, Vedunova M, Krysko DV. Which cell death modality wins the contest for photodynamic therapy of cancer? Cell Death Dis (2022) 13(5):455. doi: 10.1038/s41419-022-04851-4
10. Kessel D, Oleinick NL. Cell death pathways associated with photodynamic therapy: An update. Photochem Photobiol Sci (2018) 94(2):213–8. doi: 10.1111/php.12857
11. Yano T, Kasai H, Horimatsu T, Yoshimura K, Teramukai S, Morita S, et al. Multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget (2017) 8:22135–44. doi: 10.18632/oncotarget.14029
12. Shigeno T, Kajiyama D, Sato K, Fujiwara N, Kinugasa Y, Yano T, et al. The feasibility of post-photodynamic therapy salvage esophagectomy in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Esophagus. (2023) 20(4):643–50. doi: 10.1007/s10388-023-01020-0
13. Hu Y, Masamune K. Flexible laser endoscope for minimally invasive photodynamic diagnosis (PDD) and therapy (PDT) toward efficient tumor removal. Opt Express. (2017) 25(14):16795–812. doi: 10.1364/OE.25.016795
14. Zhao M, Wang R, Lu Y, Zhang X, Wu R, Yi L, et al. Development and clinical application of endoscopic techniques in photodynamic therapy for luminal tumors. Chin J Lasers. (2023) 50(9):0907202. doi: 10.3788/CJL221218
15. Jin F, Wang H, Li Q, Bai C, Zeng Y, Lai G, et al. Clinical application of photodynamic therapy for Malignant airway tumors in China. Thorac Cancer. (2020) 11(1):181–90. doi: 10.1111/1759-7714.13223
16. Didamson OC, Abrahamse H. Targeted photodynamic diagnosis and therapy for esophageal cancer: Potential role of functionalized nanomedicine. Pharmaceutics. (2021) 13(11):1943. doi: 10.3390/pharmaceutics13111943
17. Kresfelder TL, Cronjé MJ, Abrahamse H. The effects of two metallophthalocyanines on the viability and proliferation of an esophageal cancer cell line. Photomed Laser Surg (2009) 27(4):625–31. doi: 10.1089/pho.2008.2321
18. Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, et al. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer. Int J Oncol (2017) 50(3):953–63. doi: 10.3892/ijo.2017.3854
19. Seotsanyana-Mokhosi I, Kresfelder T, Abrahamse H, Nyokong T. The effect of Ge, Si and Sn phthalocyanine photosensitizers on cell proliferation and viability of human oesophageal carcinoma cells. J Photochem Photobiol B (2006) 83(1):55–62. doi: 10.1016/j.jphotobiol.2005.12.004
20. Crous A, Dhilip Kumar SS, Abrahamse H. Effect of dose responses of hydrophilic aluminium (III) phthalocyanine chloride tetrasulphonate based photosensitizer on lung cancer cells. J Photochem Photobiol B (2019) 194:96–106. doi: 10.1016/j.jphotobiol.2019.03.018
21. Velloso NV, Muehlmann LA, Longo JP, Silva JR, Zancanela DC, Tedesco AC, et al. Aluminum-phthalocyanine chloride-based photodynamic therapy inhibits PI3K/Akt/Mtor pathway in oral squamous cell carcinoma cells in vitro. Chemotherapy (2012) 1(107):5. doi: 10.1186/s12951-015-0095-3
22. Muehlmann LA, Rodrigues MC, Longo JP, Garcia MP, Py-Daniel KR, Veloso AB, et al. Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells. J Nanobiotechnology. (2015) 13:36. doi: 10.1186/s12951-015-0095-3
23. Ndhundhuma IM, Abrahamse H. Susceptibility of in vitro melanoma skin cancer to photoactivated hypericin versus aluminium(III) phthalocyanine chloride tetrasulphonate. BioMed Res Int (2017) 2017:5407012. doi: 10.1155/2017/5407012
24. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther (2004) 1(4):279–93. doi: 10.1016/S1572-1000(05)00007-4
25. Ndhundhuma I, Hauser C, Scalfi-Happ C, Rück A, Steiner R. Subcellular co-localization of aluminum (III) phthalocyanine chloride tetrasulphonate with fluorescent markers in the human melanoma cell-line HT-144. Med laser Appl (2011) 26(3):93–100. doi: 10.1016/j.mla.2011.04.001
26. Mahalingam SM, Ordaz JD, Low PS. Targeting of a photosensitizer to the mitochondrion enhances the potency of photodynamic therapy. ACS Omega. (2018) 3(6):6066–74. doi: 10.1021/acsomega.8b00692
27. Oliveira CS, Turchiello R, Kowaltowski AJ, Indig GL, Baptista MS. Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency. Free Radical Biol Med (2011) 51(4):824–33. doi: 10.1016/j.freeradbiomed.2011.05.023
28. Peskova NN, Brilkina AA, Gorokhova AA, Shilyagina NY, Kutova OM, Nerush AS, et al. The localization of the photosensitizer determines the dynamics of the secondary production of hydrogen peroxide in cell cytoplasm and mitochondria. J Photochem Photobiol B (2021) 219:112208. doi: 10.1016/j.jphotobiol.2021.112208
29. Sekhejane PR, Houreld NN, Abrahamse H. Multiorganelle localization of metallated phthalocyanine photosensitizer in colorectal cancer cells (DLD-1 and caCo-2) enhances efficacy of photodynamic therapy. Int J Photoenergy. (2014) 2014:383027. doi: 10.1155/2014/383027
30. Ma QL, Shen MO, Han N, Xu HZ, Peng XC, Li QR, et al. Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells. Photodiagnosis Photodyn Ther (2022) 37:102645. doi: 10.1016/j.pdpdt.2021.102645
31. O’Connor Mark J. Targeting the DNA damage response in cancer. Mol Cell (2015) 60(4):547–60. doi: 10.1016/j.molcel.2015.10.040
33. Jin MH, Oh D-Y. ATM in DNA repair in cancer. Pharmacol Ther (2019) 203:107391. doi: 10.1016/j.pharmthera.2019.07.002
34. Kciuk M, Gielecińska A, Kołat D, Kałuzińska Ż, Kontek R. Cancer-associated transcription factors in DNA damage response. Biochim Biophys Acta Rev Cancer. (2022) 1877(4):188757. doi: 10.1016/j.bbcan.2022.188757
35. Dailton Guedes de Oliveira Moraes C, Henrique Godoi B, Chaves Silva Carvalho I, Cristina Pinto J, Carvalho Rossato R, Soares da Silva N, et al. Genotoxic effects of photodynamic therapy in laryngeal cancer cells - An in vitro study. Exp Biol Med (2019) 244(3):262–71. doi: 10.1177/1535370219826544
36. El-Hussein A, Harith M, Abrahamse H. Assessment of DNA damage after photodynamic therapy using a metallophthalocyanine photosensitizer. Int J Photoenergy. (2012) 2012:281068. doi: 10.1155/2012/281068
37. Chota A, George BP, Abrahamse H. In Vitro cell death mechanisms induced by dicoma anomala root extract in combination with ZnPcS4 Mediated-photodynamic therapy in A549 lung cancer cells. Cells. (2022) 11:3288. doi: 10.3390/cells11203288
38. Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta - Mol Cell Res (2016) 1863(12):2977–92. doi: 10.1016/j.bbamcr.2016.09.012
39. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 87(1):99–163. doi: 10.1152/physrev.00013.2006
40. Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene. (2008) 27(48):6194–206. doi: 10.1038/onc.2008.297
41. Algorri JF, Ochoa M, Roldán-Varona P, Rodríguez-Cobo L, López-Higuera JM. Light technology for efficient and effective photodynamic therapy: A critical review. Cancers. (2021) 13(14):3484. doi: 10.3390/cancers13143484
42. Crous A, Abrahamse H. Aluminium (III) phthalocyanine chloride tetrasulphonate is an effective photosensitizer for the eradication of lung cancer stem cells. R Soc Open Sci (2021) 8(9):210148. doi: 10.1098/rsos.210148
43. Chizenga EP. Photodynamic therapy using sulfonated aluminium phthalocyaninemix for the eradication of cervical cancer and cervical cancer stem cells. South Africa: University of Johannesburg (South Africa (2018). [M.Tech.].
44. Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol (2022) 23(1):74–88. doi: 10.1038/s41580-021-00404-3
45. Crous A, Abrahamse H. Photodynamic therapy with an alPcS4Cl gold nanoparticle conjugate decreases lung cancer& Metastatic potential. Coatings. (2022) 12(2):199. doi: 10.3390/coatings12020199
46. Montaseri H, Simelane NWN, Abrahamse H. Zinc phthalocyanine tetrasulfonate-loaded ag@mSiO2 nanoparticles for active targeted photodynamic therapy of colorectal cancer. Front nanotechnol (2022) 4. doi: 10.3389/fnano.2022.928010
47. Epe B. DNA damage spectra induced by photosensitization. Photochem Photobiol Sci (2012) 11(1):98–106. doi: 10.1039/c1pp05190c
48. Petrilla C, Galloway J, Kudalkar R, Ismael A, Cottini F. Understanding DNA damage response and DNA repair in multiple myeloma. Cancers (2023) 15(16):4155–68. doi: 10.3390/cancers15164155
49. Guleria A, Chandna S. ATM kinase: Much more than a DNA damage responsive protein. DNA repair. (2016) 39:1–20. doi: 10.1016/j.dnarep.2015.12.009
50. Moon S-H, Nguyen T-A, Darlington Y, Lu X, Donehower LA. Dephosphorylation of γ-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle (2010) 9(11):2092–6. doi: 10.4161/cc.9.11.11810
51. Wei X, Ni J, Yuan L, Li X. Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway. Oncol Lett (2024) 27(1):17. doi: 10.3892/ol.2023.14150
52. Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol (2019) 25:101084. doi: 10.1016/j.redox.2018.101084
53. Sahoo BM, Banik BK, Borah P, Jain A. Reactive oxygen species (ROS): Key components in cancer therapies. Anticancer Agents Med Chem (2022) 22(2):215–22. doi: 10.2174/1871520621666210608095512
54. Hüttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, Samavati L, et al. The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion. (2011) 11(3):369–81. doi: 10.1016/j.mito.2011.01.010
55. Mfouo-Tynga I, Houreld NN, Abrahamse H. Evaluation of cell damage induced by irradiated Zinc-Phthalocyanine-gold dendrimeric nanoparticles in a breast cancer cell line. BioMed J (2018) 41(4):254–64. doi: 10.1016/j.bj.2018.05.002
56. Marino J, García Vior MC, Furmento VA, Blank VC, Awruch J, Roguin LP. Lysosomal and mitochondrial permeabilization mediates zinc(II) cationic phthalocyanine phototoxicity. Int J Biochem Cell Biol (2013) 45(11):2553–62. doi: 10.1016/j.biocel.2013.08.012
57. Valli F, García Vior MC, Roguin LP, Marino J. Oxidative stress generated by irradiation of a zinc(II) phthalocyanine induces a dual apoptotic and necrotic response in melanoma cells. Apoptosis. (2019) 24(1):119–34. doi: 10.1007/s10495-018-01512-w
58. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol (2013) 5(4):a008656. doi: 10.1101/cshperspect.a008656
Keywords: photodynamic therapy, oxidative stress, cell cycle, DNA damage response, cell death, apoptosis
Citation: Didamson OC, Chandran R and Abrahamse H (2024) Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells. Front. Oncol. 14:1338802. doi: 10.3389/fonc.2024.1338802
Received: 15 November 2023; Accepted: 10 January 2024;
Published: 29 January 2024.
Edited by:
Newton Soares Da Silva, Sao Paulo State University, BrazilReviewed by:
Ana Salomé Pires, University of Coimbra, PortugalKatarina Stroffekova, University of Pavol Jozef Šafárik, Slovakia
Copyright © 2024 Didamson, Chandran and Abrahamse. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Heidi Abrahamse, aGFicmFoYW1zZUB1ai5hYy56YQ==